CDEK
← All organizations

YM Biosciences

For profit

Also known as: CIMYM BioSciences | YM BioSciences | YM Biosciences Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2001

Last known activity

Jan 1, 2012

Acquired by Gilead Sciences on Feb 11, 2013

Timeline

1990s

  1. Jan 1, 1994

    YM Biosciences— Founded

2000s

  1. Apr 1, 2006

    Eximias Pharmaceutical— Acquired

2010s

  1. Feb 11, 2013

    Gilead Sciences— Acquired By

Drugs by trial phase (6 distinct, 16 trials)

Phase 3 (1 own, 2 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (21)

Details

Founded
Toronto, CA Jan 1, 1994
Last known activity
Jan 1, 2012